AU2002234132A1 - 13245, a novel human myotonic dystrophy type protein kinase and uses therefor - Google Patents

13245, a novel human myotonic dystrophy type protein kinase and uses therefor

Info

Publication number
AU2002234132A1
AU2002234132A1 AU2002234132A AU3413202A AU2002234132A1 AU 2002234132 A1 AU2002234132 A1 AU 2002234132A1 AU 2002234132 A AU2002234132 A AU 2002234132A AU 3413202 A AU3413202 A AU 3413202A AU 2002234132 A1 AU2002234132 A1 AU 2002234132A1
Authority
AU
Australia
Prior art keywords
protein kinase
type protein
myotonic dystrophy
nucleic acid
dystrophy type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002234132A
Inventor
Rosana Kapeller-Libermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU2002234132A1 publication Critical patent/AU2002234132A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

The invention provides isolated nucleic acids molecules, designated 13245 nucleic acid molecules, which encode a novel myotonic dystrophy type protein kinase. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 13245 nucleic acid molecules, host cells into which the expression vectors have been introduced, and non-human transgenic animals in which a 13245 gene has been introduced or disrupted. The invention still further provides isolated 13245 proteins, fusion proteins, antigenic peptides and anti-13245 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
AU2002234132A 2000-10-23 2001-10-23 13245, a novel human myotonic dystrophy type protein kinase and uses therefor Abandoned AU2002234132A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24242900P 2000-10-23 2000-10-23
US60/242,429 2000-10-23
PCT/US2001/050636 WO2002034896A2 (en) 2000-10-23 2001-10-23 13245, a novel human myotonic dystrophy type protein kinase and uses therefor

Publications (1)

Publication Number Publication Date
AU2002234132A1 true AU2002234132A1 (en) 2002-05-06

Family

ID=22914754

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002234132A Abandoned AU2002234132A1 (en) 2000-10-23 2001-10-23 13245, a novel human myotonic dystrophy type protein kinase and uses therefor

Country Status (9)

Country Link
US (2) US6946274B2 (en)
EP (1) EP1328621B1 (en)
AT (1) ATE349515T1 (en)
AU (1) AU2002234132A1 (en)
DE (1) DE60125569T2 (en)
DK (1) DK1328621T3 (en)
ES (1) ES2279833T3 (en)
PT (1) PT1328621E (en)
WO (1) WO2002034896A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638745B1 (en) * 2001-03-13 2003-10-28 Applera Corporation Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
AU2003234717A1 (en) * 2002-04-12 2003-10-27 Bristol-Myers Squibb Company Novel polynucleotides encoding the human citron kinase polypeptide, bmsnkc 0020/0021
US20090088400A1 (en) 2007-09-11 2009-04-02 Puymirat Jack Prostaglandin e2 modulation and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1240194A2 (en) 1999-11-24 2002-09-18 Sugen, Inc. Novel human protein kinases and protein kinase-like enzymes

Also Published As

Publication number Publication date
US20020160483A1 (en) 2002-10-31
DE60125569T2 (en) 2007-10-04
US20050233375A1 (en) 2005-10-20
EP1328621B1 (en) 2006-12-27
EP1328621A2 (en) 2003-07-23
US6946274B2 (en) 2005-09-20
WO2002034896A3 (en) 2002-10-24
WO2002034896A2 (en) 2002-05-02
ES2279833T3 (en) 2007-09-01
PT1328621E (en) 2007-03-30
DK1328621T3 (en) 2007-04-10
DE60125569D1 (en) 2007-02-08
ATE349515T1 (en) 2007-01-15

Similar Documents

Publication Publication Date Title
WO2001072976A3 (en) 32142, 21481, 25964, 21686, novel human dehydrogenase molecules and uses therefor
WO2001090325A3 (en) 50365, a hexokinase family member and uses thereof
WO2002006302A3 (en) 16816 and 16839, novel human phospholipase c molecules and uses therefor
AU2001280639A1 (en) 13237,18480,2245 or 16228 human protein kinase molecules and uses therefor
AU2001249649A1 (en) 16836, a novel human phospholipase c family member and uses thereof
WO2001064904A3 (en) 25324, 50287, 28899, 47007, and 42967 transferase family members and uses therefor
AU2002234132A1 (en) 13245, a novel human myotonic dystrophy type protein kinase and uses therefor
WO2001075076A3 (en) 33167, a novel human hydrolase and uses therefor
WO2001064905A3 (en) 2504, 15977, and 14760, novel protein kinase family members and uses therefor
WO2003020912A3 (en) Novel clark protein and nucleic acid molecules and uses therefor
WO2001066764A3 (en) 16835, a human phospholipase c and uses thereof
WO2002006485A3 (en) 47885, a novel human ubiquitin-activating enzyme and uses therefor
WO2002020801A3 (en) 26199, 33530, 33949, 47148, 50226, and 58764, human transferase family members and uses therefor
WO2002010401A3 (en) 18431 and 32374, human protein kinase family members and uses therefor
WO2002006331A3 (en) 14087, a serine protease molecule and uses therefor
WO2002024921A3 (en) 3700, a novel human protein kinase and uses therefor
WO2002029037A3 (en) 57800, a novel human cadherin and uses therefor
WO2001081584A3 (en) 27960, a novel ubiquitin conjugating enzyme family member and uses therefor
WO2002038773A3 (en) A human phospholipase c and uses thereof
WO2001073051A3 (en) 46743 and 27417, novel human acyltransferase family members and uses therefor
WO2002020738A3 (en) 27877, a phospholipase and uses therefor
WO2002024925A3 (en) 69109, a novel human tyrosine phosphatase and uses therefor
WO2002000841A3 (en) 58199, a membrane-associated protein and uses therefor
WO2002040657A3 (en) 47169 and 33935, novel glycosyl transferases and uses therefor
WO2002008394A3 (en) 23430, a novel human ubiquitin hydrolase family member and uses therefor